Researchers Arrive at the 'Holy Grail' of HIV Immunity

The University of Melbourne's latest insight into immunity to HIV could help to develop a vaccine to build antibodies' defences against the disease.

By investigating the action of the human antibodies called ADCC, in people with HIV, researchers were able to identify that the virus evolves to evade or 'escape' the antibodies.

AIDS/HIV - Prevention
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV

Professor Stephen Kent of the University of Melbourne and one of the senior authors on the paper said ADCC antibodies have been strongly implicated in protection from HIV in several vaccine trials but their action was poorly understood.

"These results show what a slippery customer the HIV virus is, but also shows that these ADCC antibodies are really forcing the virus into changing, in ways that cause it to be weaker," said Kent.

"It also implies that if good ADCC antibodies were available prior to infection, via a vaccine, we might be able to stop the virus taking hold. This is the holy grail," added Kent.

HIV Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical Features

The group at the University of Melbourne's Department of Microbiology and Immunology analysed blood samples of people with HIV and found their virus had evolved to evade or 'escape' the ADCC antibodies against HIV they are making to try to control their virus.

The work has been published in the prestigious international journal PNAS.

Lab Test for AIDS/HIV
Describes how screening for HIV is performed in a laboratory.

Source-ANI

AIDS and Pregnancy - Treatment - Caring HIV Babies
The Acquired immune deficiency syndrome is brought about by the deadly human immunodeficiency virus. In the USA alone an estimate of 120,000 - 160,000 women are HIV- infected.